Cytokines IL-1α, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: Restoration by interferon γ

Cancer Immunology, Immunotherapy

Volumn 53, Issue 1, 2004, Pages 33-40

  Thomas, Giovana R ^a   Chen, Zhong ^b   Leukinova, Elena ^b   Van Waes, Carter ^b   Wen, Judy ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

CD80; Cytokines; IFN ; Regulation; Squamous cell carcinoma

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CYTOKINE RELEASE; DOWN REGULATION; HEAD AND NECK CARCINOMA; IMMUNOREGULATION; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANIMALS; ANTIGENS, CD80; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MOUTH NEOPLASMS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0742269447     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0433-4     Document Type: Article

References (33)

1. . Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell costimulation. Ann Rev Immunol 14:233
2. Sperling AI, Bluestone JA (1996) The complexities of T cell costimulation: CD28 and beyond. Immunol Rev 153:155
3. Chambers CA, Allison JP (1997) Co-stimulation in T cell responses. Curr Opin Immunol 9:396
4. Schwartz RH (1996) Models of T cell anergy: is there a common molecular mechanism? J Exp Med 184:1
5. Cozzolino F, Torcia M, Carossino A, Giordani R, Selli C, Talini G, Reali E, Novelli A, Pistoia V, Ferrarini M (1987) Characterization of cells from invaded lymph nodes in patients with solid tumors: lymphokine requirement for tumor-specific lymphoproliferative responses. J Exp Med 166:303
6. Burkey BB, Omann GM, Wolf GT (1991) Intracellular calcium changes associated with in vitro lymphokine activated killer and natural killer cell cytotoxicity. Arch Otolaryngol Head Neck Surg 117:1281
7. Bennet S, Futrell J, Roth J, Hoye R, Kecham A (1971) Prognostic significance of histologic host response in cancer in the larynx or hypopharynx. Cancer 28:1255
8. Lang S, Atarashi Y, Nishioka Y, Stanson J, Meidenbauer N, Whiteside TL (2000) B7-1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death. Cellular Immunol 201(2):132
9. Lang S, Whiteside TL, Lebeau A, Zeidler R, Mack B, Wollenberg B (1999) Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration. Arch Otolaryngol Head Neck Surg 125(1): 82
10. Thomas GR, Chen Z, Oechsli M, Hendler JH, Van Waes C (1999) Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma. Int J Cancer 82:377
11. Smith CW, Chen Z, Dong G, Loukinova E, Pegram MY, Nicholas-Figueroa L, Van Waes C (1998) The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC. Clin Exp Metastasis 16(7): 655
12. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh, Mousa S, Quezado M, Herscher LL, Van Waes C (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5:1369
13. Van Waes C, Chen Z, Callister M, Colon I, Ortiz N, Smith C, Thomas GR, Dong G (2000) Cytokines in the immune pathogenesis and therapy of head and neck cancer. In: Veldman JE, Passali D, Lim DJ (eds) New frontiers in immunobiology. Kugler, Netherlands, p 233
14. Woodworth C, McMullin E, Iglesias M, Plowman G (1995) Interleukin 1 α and tumor necrosis factor a stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci U S A 92:2840
15. Stevenson FT, Turck J, Locksley RM, Lovett DH (1997) The N-terminal propiece of interleukin 1 α is a transforming nuclear oncoprotein. Proc Natl Acad Sci U S A 94:508
16. Loukinova E, Dong G, Enamorado I, Thomas GR, Chen Z, Schreiber H, Van Waes C (2000) Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 19(31):3477
17. Pak A, Wright M, Matthews J, Collins S, Petruzzelli G, Young M (1995) Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34+ cells, which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor 1. Clin Cancer Res 1:95
18. Cheng X, Lopez DM (1998) CD4+ , but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma: role of phosphatidyl serine. J mmunol 160(6):2735
19. Thomas GR, Chen Z, Enamorado I, Bancroft C, Van Waes C (2000) IL-12 and IL-2 induced tumor regression in a new murine model of oral squamous cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-γ. Int J Cancer 86:368
20. DeVita VT, Hellman S, Rosenberg SA (eds) (1995) Biologic therapy of cancer. Lippincott, Philadelphia
21. Blankenstein T, Rowley, DA, Schreiber H (1991) Cytokines and cancer: experimental systems. Curr Opin Immunol 3(5):694
22. Paul WE (ed) (1993) Fundamental immunology, 3rd edn. Raven Press, New York
23. Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N, Van Waes C (2001) IL (interleukin)-1alpha promotes nuclear factor-kappa B and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 7(6): 1812
24. Young MR, Wright MA, Lozano Y, Prechel MM, Benefield J, Leonetti JP, Collins SL, Petruzzelli GJ (1997) Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int J Cancer 74(1):69
25. Ratta M, Fagnoni F, Curti A, Vescovini R, Sansoni P, Oliviero B, Fogli M, Ferri E, Della Cuna GR, Tura S, Baccarani M, Lemoli RM (2002) Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood 100(1):230
26. Jennings R, Munoz-Antonia T, Zhu Z, Jackson R, Antonia S (1999) Identification of an enhancer element in the mouse B7-1 promoter. Immunogenetics 50:109
27. Foss DL, Zilliox MJ, Murtaugh MP (1999) Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins. Infect Immun 67(10):5275
28. Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fisher FW (1994) IL-4 treatment of small splenic B cells induces co-stimulatory molecules B7-1 and B7-2. J Immunol 152:5723
29. Hatcock KS, Laszlo G, Pucillo C, Linsley P, Rodes RJ (1994) Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: expression and function. J Exp Med 180:631
30. Caux C, Massacrier C, Vanberviet B, Dubois B, Van Kooten C, Durand I, Banchereau J (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263
31. Ranheim EA, Kipps TJ (1995) Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cell Immunol 161:226
32. Friedman AS, Freeman GJ, Rhynhart K, Nadler LM (1991) Selective induction of B7/BB1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 137:429
33. Schreiber H, Wu TH, Nachman J, Kast WM (2002) Immunodominance and tumor escape. Semin Cancer Biol 12:35